GLA
MIRM icon

Great Lakes Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Great Lakes Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$757K Hold
6,465
– – 0.01% 563
2026
Q1 		$597K Hold
6,465
– – 0.01% 572
2025
Q4 		$511K Hold
6,465
– – ﹤0.01% 608
2025
Q3 		$474K Hold
6,465
– – ﹤0.01% 625
2025
Q2 		$329K Hold
6,465
– – ﹤0.01% 686
2025
Q1 		$291K Hold
6,465
– – ﹤0.01% 695
2024
Q4 		$267K Hold
6,465
– – ﹤0.01% 744
2024
Q3 		$252K Sell
6,465
-1,843
-22% -$73.5K ﹤0.01% 771
2024
Q2 		$284K Hold
8,308
– – ﹤0.01% 738
2024
Q1 		$209K Sell
8,308
-1,192
-13% -$32.8K ﹤0.01% 775
2023
Q4 		$280K Buy
+9,500
New +$288K ﹤0.01% 682

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Great Lakes Advisors's MIRM Position: Q2 2026 in Review

Great Lakes Advisors held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 6,465 shares worth $757K. The position accounts for 0.01% of the portfolio, ranked #563.

Great Lakes Advisors first reported a position in MIRM in Q4 2023 and has held it in 11 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Great Lakes Advisors held 6,465 shares of Mirum Pharmaceuticals worth $757K as of Q2 2026.
  • Great Lakes Advisors left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up 0.01% of Great Lakes Advisors's portfolio in Q2 2026, its #563 holding.
  • Great Lakes Advisors first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.